.png){kind=icon}
返回
Computational Method to Evaluate Progress in Lead Optimization
.png){kind=icon}
PRE
AI
DOI：10.1021/acs.jmedchem.8b01626.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
In medicinal chemistry, lead optimization is a critically important task and a highly empirical process, largely driven by chemical knowledge and intuition. Only very few approaches are available to guide and evaluate optimization efforts. It is often very difficult to understand when a compound series is exhausted and the generation of additional analogs unlikely to yield further progress toward potent and efficacious candidates. Rationalizing lead optimization remains an essentially unsolved problem. Herein, we introduce a new computational method to aid in evaluating whether sufficient numbers of analogs have been made and further progress is unlikely. The approach integrates the assessment of chemical saturation and structure-activity relationship progression of compound series. Easy-to-calculate scores characterize evolving analog series and identify candidates with high or low priority for further chemical exploration.
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
6.8
论文数:
2.7W
被引数:
9.4W
机构
引用论文
External facial features modify the representation of internal facial features in the fusiform face area.png)
NeuroImage
NeuroImageIF0
PREAI
分享收藏Lead optimization attrition analysis (LOAA): a novel and general methodology for medicinal chemistryDRUG DISCOVERY TODAY
DRUG DISCOVERY TODAYIF7.5
PREAI
分享收藏Monitoring the Progression of Structure-Activity Relationship Information during Lead Optimization
PREAI
分享收藏Computational Assessment of Chemical Saturation of Analogue Series under Varying ConditionsACS OMEGA
OAAI
ACS OMEGAIF4.3
OAAI分享收藏
查看更多内容